Tokyo, July 18 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058505) titled 'Atopic Dermatitis in Clinical Practice Patient Reported Outcome(PRO)Fact-Finding Study' on July 18.
Study Type:
Observational
Primary Sponsor:
Institute - Otsuka Pharmaceutical Co., Ltd.
Condition:
Condition - Atopic Dermatitis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Investigate the actual use of PRO in atopic dermatitis practice
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Physicians who meet all of the following selection criteria will be included in this study
Outpatient services, Treated at least 10 patients with atopic dermatitis in the last month, The individual's consent to participate in the research is obtained
Key exclusion criteria - No exclusion criteria are set
Target Size - 400
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 06 Month 09 Day
Date of IRB - 2025 Year 06 Month 18 Day
Anticipated trial start date - 2025 Year 07 Month 18 Day
Last follow-up date - 2025 Year 07 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066890
Disclaimer: Curated by HT Syndication.
